Cart
sales@molnova.com
Panobinostat
CAS No. 404950-80-7
Panobinostat ( LBH-589;LBH589;NVP-LBH589 )
Catalog No. M14388 CAS No. 404950-80-7
A potent, broad-spectrum HDAC inhibitor with IC50 of 5-20 nM in cell-free assyas.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 47 | In Stock |
|
| 25MG | 72 | In Stock |
|
| 50MG | 96 | In Stock |
|
| 100MG | 132 | In Stock |
|
| 200MG | 168 | In Stock |
|
| 500MG | 345 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePanobinostat
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, broad-spectrum HDAC inhibitor with IC50 of 5-20 nM in cell-free assyas.
-
DescriptionA potent, broad-spectrum HDAC inhibitor with IC50 of 5-20 nM in cell-free assyas; induces cell-cycle arrest, apoptosis, and histone (H3K9 and H4K8) hyperacetylation, increases mRNA levels of proapoptosis, growth arrest, and DNA damage repair genes including FANCG, FOXO3A, GADD45A, GADD45B, and GADD45G; significantly slows tumor growth derived from Meso and NSCLC cells in vivo models.Blood Cancer Approved
-
SynonymsLBH-589;LBH589;NVP-LBH589
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC(MOLT-4cells);HDAC(Rehcells)
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number404950-80-7
-
Formula Weight349.43
-
Molecular FormulaC21H23N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 57 mg/mL
-
SMILESO=C(NO)/C=C/C1=CC=C(CNCCC2=C(C)NC3=C2C=CC=C3)C=C1
-
Chemical Name2-Propenamide, N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Crisanti MC, et al. Mol Cancer Ther. 2009 Aug;8(8):2221-31.
2. George P, et al. Blood. 2005 Feb 15;105(4):1768-76.
3. Scuto A, et al. Blood. 2008 May 15;111(10):5093-100.
2. George P, et al. Blood. 2005 Feb 15;105(4):1768-76.
3. Scuto A, et al. Blood. 2008 May 15;111(10):5093-100.
molnova catalog
related products
-
Encorafenib
LGX818 is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.
-
SB-379278A
A potent and selective HDAC8 inhibitor with IC50 of 0.5 uM.
-
BML-210
A novel histone deacetylase (HDAC) inhibitor that induces Ac-histone in A549 cells with EC50 of 181 uM.
